This bill eliminates the District of Columbia Judicial Nominating Commission. It changes the process for appointing D.C. judges by requiring the President to directly nominate candidates, removing the requirement to use a list recommended by the former commission. The key change is shifting the nomination authority from the commission to the President, with all appointments made after the bill's enactment subject to this new process. The bill also makes minor technical updates to related laws to remove references to the now-terminated commission.
S 2907, the Chloe Cole Act, prohibits health care professionals, hospitals, or clinics from performing "chemical or surgical mutilation" on minors under 18. This includes using puberty blockers, sex hormones, or surgeries intended to alter a child's body to align with a gender identity different from their sex assigned at birth. The law creates a private right of action, allowing victims or their guardians to sue providers in federal court for damages - including emotional distress and punitive damages - unless the treatment qualifies under specific exceptions (e.g., medically necessary care for disorders of sexual development, injuries, or detransition). It explicitly excludes counseling, referrals, or discussions of treatment options from liability, and sets a 25-year statute of limitations for lawsuits starting from the victim’s 18th birthday.
S 2870, the "Fight Illicit Pill Presses Act," requires manufacturers, distributors, and sellers of tableting machines (used to make pills) and their key components (like punches and dies) to permanently affix serial numbers to these items. It mandates that regulated businesses report these serial numbers to the Attorney General and prohibits removing, altering, or trafficking in machines or parts with tampered serial numbers. This law directly affects businesses involved in producing, selling, or distributing pill-making equipment, aiming to improve tracking of machines potentially used for illicit drug manufacturing. The bill amends the Controlled Substances Act to create new recordkeeping and reporting requirements for these specific machines and parts.
This bill requires Medicare Advantage (MA) plans to pay 95% of complete medical claims within 14 days (for electronic claims) or 30 days (for paper claims) after receipt. If payments are late, MA plans must pay interest at the federal penalty rate and face civil penalties of up to $25,000 per violation. Plans must also publicly report annual data on payment timeliness, including breakdowns for claims under contract versus not under contract with providers. The rules apply to all MA organizations for services provided on or after January 1, 2027.
This bill strengthens rights for crime victims in federal cases by requiring the government to inform victims about their rights, including details about plea bargains, agreements, and legal assistance options. It creates a new process for victims to file complaints about rights violations with a Department of Justice Administrative Authority, which must issue decisions within 180 days. The bill also mandates trauma-informed training for DOJ staff, requires the DOJ to report on implementation, and allows victims to seek attorney's fees if they successfully assert their rights. These changes apply to all federal criminal cases where a victim has been directly harmed by an offense.
The SEVER Act amends existing law to deny visas to representatives of foreign governments who serve at the United Nations and are subject to sanctions under Executive Order 13876 (relating to Iran). It directly affects UN delegates from countries targeted by these specific Iran sanctions. The key provision adds a new category to visa denial criteria, requiring U.S. visa officials to block entry for such representatives based on existing sanctions authority. This change modifies Section 407(a)(1) of the Foreign Relations Authorization Act without creating new sanctions or altering the underlying Iran policy.
This federal bill requires abortion providers to inform patients about potential reversal of mifepristone-based chemical abortions (the two-drug process) at least 24 hours before the procedure. After the first drug is dispensed, providers must give written instructions stating that reversal may be possible if the second pill hasn't been taken. Facilities must post visible signs about reversal options, and the government must maintain a website with reversal resources. Violations allow affected patients or family members to sue for damages.
This bill requires most health insurance plans, Medicare Part D, Medicaid, and CHIP to cover vaccines recommended by the CDC's Advisory Committee on Immunization Practices (ACIP) without cost-sharing (like copays or deductibles). It applies to vaccines recommended as of October 25, 2024, including updates through 2029, and covers all such vaccines for the period starting when the bill is enacted until December 31, 2029. The requirement excludes vaccines given within minimum recommended intervals. It directly affects patients, insurers, and government health programs by ensuring no out-of-pocket costs for covered vaccines during this timeframe.
The "No DEI in DC Act" (HR 5474) prohibits the District of Columbia government from engaging in what it defines as "prohibited diversity, equity, and inclusion practices." This includes banning DEI training programs, requiring employees to sign statements about race or gender, and maintaining offices focused on diversity issues. The bill abolishes numerous DC offices and commissions related to diversity, such as the Mayor's Office of Racial Equity, Commission on Health Equity, and LGBTQ-focused offices. It also prohibits using District funds for DEI-related activities or maintaining DEI-focused offices, with the law taking effect 90 days after enactment.
The Tyler Clementi Higher Education Anti-Harassment Act of 2025 requires U.S. colleges and universities participating in federal financial aid programs to create and distribute clear anti-harassment policies covering harassment based on race, color, national origin, sex (including sexual orientation and gender identity), disability, or religion. These policies must explicitly prohibit harassment in all settings - including online, on campus, off-campus housing, and during school-sponsored activities - and outline reporting procedures and support services for victims. The bill also establishes a $50 million annual grant program to fund schools developing prevention programs, victim support services, or staff/student training on recognizing and addressing harassment. Grants are competitive, require annual reporting on effectiveness, and must be used to improve existing efforts without replacing existing civil rights laws like Title IX.
HR 5459 adjusts the Congressional summer schedule by moving the start of the summer break from July 31 to June 30 and ending the break earlier, shifting the end date from Labor Day to the first Monday in August. This procedural bill directly affects Congress's calendar, changing when lawmakers return from summer recess. The amendments take effect when the second session of the 119th Congress convenes. It does not alter policy or impact the public.
HR 5483, the Chloe Cole Act, prohibits health care professionals, hospitals, or clinics from providing certain gender-affirming treatments to minors under 18 that aim to alter their body to align with a gender identity different from their sex assigned at birth. This includes puberty blockers, sex hormones, and specific surgeries, unless the treatment falls under narrow exceptions like medically necessary care for disorders of sexual development, injuries, or detransition. The bill creates a private right for affected minors or their guardians to sue providers for damages in federal court, with strict liability for violations. It applies when interstate commerce is involved (e.g., payments, travel, communications) and sets a 25-year statute of limitations from the minor’s 18th birthday.
